Luciferase Activity (Relative Light Units/mn): mean (SE), n | |||||
---|---|---|---|---|---|
Time post-infection: | 48 h | 96 h | 120 h | 168 h | 216 h |
HIV-1/Delta-Env (20 ng*) | 2,660 (356), 3 | 3,300 (1,637), 3 | 2,830 (911), 6 | ||
HIV-1/VSV-G (0.2 ng*) | 4,010 (1,224), 3 | 14,110 (9,591),3 | 5,420 (4,152), 3 | ||
HIV-1/VSV-G (2 ng*) | 14,520 (16,718), 3 | 77,880 (22,016), 3 | 93,640 (34,095), 7 | ||
HIV-1/VSV-G (20 ng*) | 213,190 (195,249), 3 | 1,266,430 (449,346), 3 | 1,397,280 (861,789), 3 | ||
HIV-1/Ba-L (20 ng*) | 2,562 (312), 6 | 2,535 (475), 5 | 2,670 (286), 4 | ||
HIV-1/Ba-L (50 ng*) | 3,830 (3,612), 6 | 10,380 (7,478), 5 | 2,625 (772), 4 | ||
HIV-1/HXB2 (50 ng*) | 2,620 (827), 3 | 3,010 (135), 3 | 2,210 (399), 3 | ||
HIV-1/HXB2 (100 ng*) | 2,950 (458), 3 | 2,860 (255), 3 | 2,580 (1,046), 3 |